18-Gy craniospinal irradiation remains unsupported for unselected standard-risk medulloblastoma
Pooled five-year disease-control survival was 81.0% after 23.4-Gy CSI versus 71.3% after 18 Gy, supporting caution with further dose reduction.
Pooled five-year disease-control survival was 81.0% after 23.4-Gy CSI versus 71.3% after 18 Gy, supporting caution with further dose reduction.
Gamma irradiation induced p53/p21-dependent senescence in ONS76 medulloblastoma cells, which could subsequently be eliminated by several senolytic agents in vitro.
Radiographic brain injury occurred in 16% of children, all asymptomatic; every affected patient had received high-dose chemotherapy.
SMART-BRAIN proton planning spared portions of non-target brain while maintaining target coverage in five medulloblastoma cases.